Docking and SAR studies of calystegines: Binding orientation and influence on pharmacological chaperone effects for Gaucher’s disease
Authors:
- 1 April 2014
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 22 (8) , 2435-2441
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
This publication has 24 references indexed in Scilit:
- Gaucher diseaseCurrent Opinion in Chemical Biology, 2007
- Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's diseaseThe International Journal of Biochemistry & Cell Biology, 2005
- ERAD: the long road to destructionNature Cell Biology, 2005
- Gaucher disease: complexity in a “simple” disorderMolecular Genetics and Metabolism, 2004
- Characterization of two α-galactosidase mutants (Q279E and R301Q) found in an atypical variant of Fabry diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2000
- Sugar-mimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic applicationTetrahedron: Asymmetry, 2000
- Accelerated transport and maturation of lysosomal α–galactosidase A in Fabry lymphoblasts by an enzyme inhibitorNature Medicine, 1999
- Gaucher Disease: Gene Frequencies and Genotype/Phenotype CorrelationsGenetic Testing, 1997
- Characterization of a Mutant α-Galactosidase Gene Product for the Late-Onset Cardiac Form of Fabry DiseaseBiochemical and Biophysical Research Communications, 1993
- Metabolism of glucocerebrosides II. Evidence of an enzymatic deficiency in Gaucher's diseaseBiochemical and Biophysical Research Communications, 1965